Breaking news
Iran war live updates: Tehran keeps up strikes as Gulf states deny missile shortages
Middle East conflict adds to central bank headaches as oil extends four-day rally A widening Middle East conflict has posed a fresh test for global central banks, as fears of an oil shock and renewed inflation risks complicate policymakers’ calculus for shoring up growth. Brent crude prices extended four days of gains, rising 1.6% to $82.76 […]
Read More
New York Fed’s Williams says tariff burden falls ‘overwhelmingly’ on U.S. businesses and consumers
Key Points American consumers and businesses are taking most of the hit from President Donald Trump’s tariffs, New York Fed President John Williams said in remarks that counter White House claims. A study Williams cited on the issue has generated a fair amount of controversy over the past few weeks, with White House economist Kevin […]
Read More
Iran war live updates: U.S. embassy in Riyadh hit by drones, Trump promises response ‘soon’
Trump touts ‘virtually unlimited’ U.S. munitions; UAE, Qatar deny weapons’ shortage President Donald Trump said Tuesday that the U.S. has a “virtually unlimited supply” of munitions as the war with Iran escalates. He added that the stockpiles “at the medium and upper medium grade” have never been higher or better. It was not immediately clear […]
Read More
South Korea defense stocks soar with heavyweight Hanwha Aerospace surging 22% as traders react to Iran war
A Cheongung missile launcher is displayed during the Seoul International Aerospace and Defense Exhibition (ADEX 2025) at Seoul Air Base in Seongnam, Gyeonggi Province, South Korea, on October 17, 2025. Nurphoto | Nurphoto | Getty Images South Korean defense stocks saw massive gains on Tuesday after the country’s markets returned from a public holiday, as […]
Read More
Live updates: Iran security chief Ali Larijani rejects U.S. talks, blames Trump for ‘chaos’
Follow the latest news after the U.S. and Israel launched a massive attack on Iran that killed Iran’s Supreme Leader Ayatollah Ali Khamenei. Source
Read More
Core wholesale prices rose 0.8% in January, much more than expected
Customers shops for fruit in a supermarket in New York on Jan. 22, 2026. Charly Triballeau | AFP | Getty Images Wholesale prices rose at a faster-than-expected pace in January, countering hopes that inflation was easing, the Bureau of Labor Statistics reported Friday. The core producer price index, which excludes volatile food and energy prices, […]
Read More
Rolls-Royce raises outlook, plans up to $12 billion share buyback as engine demand boosts growth
Rolls-Royce said Thursday it expects profits of over £4 billion ($5.42 billion) this year as the aero engine and power systems maker promised another year of robust growth. The aerospace giant is targeting underlying operating profit of between £4 billion and £4.2 billion in 2026, above the midpoint of £3.65 billion as expected by analysts […]
Read More
Nvidia’s Jensen Huang says markets ‘got it wrong’ on AI threat to software companies
Nvidia CEO Jensen Huang delivers a keynote address at the Consumer Electronics Show in Las Vegas, Nevada, on Jan. 6, 2025. Patrick T. Fallon | Afp | Getty Images Nvidia CEO Jensen Huang said Wednesday markets have miscalculated the AI threat to software companies in an interview hours after the chip behemoth issued an upbeat […]
Read More
Fed’s Goolsbee calls for a hold on cuts as current rate of inflation is ‘not good enough’
Austan Goolsbee, president and chief executive officer of the Federal Reserve Bank of Chicago, speaks during the National Association of Business Economics (NABE) economic policy conference in Washington, DC, US, on Tuesday, Feb. 24, 2026. Graeme Sloane | Bloomberg | Getty Images Chicago Federal Reserve President Austan Goolsbee said Tuesday that interest rate cuts aren’t […]
Read More
Novo Nordisk sinks 10% after weight loss drug fails to match Eli Lilly’s in trial
Novo Nordisk stock fell over 10% Monday after it said its next-generation weight loss drug didn’t meet its primary target. The drug, CagriSema, didn’t achieve its primary endpoint of demonstrating non-inferiority on weight loss when compared to Eli Lilly‘s rival drug tirzepatide after 84 weeks, Novo said in a statement Monday morning. Eli Lilly‘s stock […]
Read More